“…A 25% of active pharmaceutical ingredient contains amide scaffold due to its broad spectrum activity (Ghose et al, 1999). The benzamide moiety (A) was usually incorporated in hybrid molecules due to glucokinase activators (Mao et al, 2012), anticancer (Chandregowda et al, 2009;El-Hashash et al, 2018), central nervous systems of a 5-HT receptor (Dumuis et al, 1989), antiviral (Wu et al, 2017), anti-inflammatory (Tumer et al, 2017), 11β-HSD1 inhibitors (Rew et al, 2009), antiprion (Fiorino et al, 2012), antioxidant (Perin et al, 2018), histone deacetylase inhibitors (Lu et al, 2011), antitumor (Zhang et al, 2022), antifungal (Zhang et al, 2016), and antimicrobial activity (Ibrahim et al, 2016). Moreover, the hybrid compound is an artificial combination of two or more pharmacophores for triggering the desired activity (Alkhzem et al, 2022) such artificial scaffolds would able to act as an antibiotic with the ability to overcome drug resistance, intensify activity and increase binding affinity.…”